CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a graphene-based biosensor platform for real-time detection of protease biomarkers in serum, particularly for predicting treatment responses in major depressive disorder. The technology aims to enhance personalized therapy and improve patient outcomes.
Proteases recently emerged as a promising new class of biomarkers with a broad diagnostic, prognostic and therapeutic potential for different human diseases including neurological and psychiatric diseases, several types of cancer, and immune system disorders.
However, there is a lack of tools for real-time activity analysis of disease-related protease biomarkers.
To address this issue, we propose to develop a highly sensitive graphene-based biosensor platform for parallel detection of multiple p…
UNIVERSITY OF APPLIED SCIENCES
HOCHSCHULE KAISERSLAUTERN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, DONOSTIA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
JOHANNES GUTENBERG-UNIVERSITAT MAINZ
Germany, Mainz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, WATERLOO
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
